Effect of a booster dose of serogroup B meningococcal vaccine on antibody response to Neisseria meningitidis in mice vaccinated with different immunization schedules

FEMS Immunology and Medical Microbiology

Volumn 44, Issue 1, 2005, Pages 35-42

  Gioia, Carolina A C ^a,b   De Sousa, Adriana B ^b   Cruz, Simone C ^b   Junior, Feliciano C S ^b   Andrade, Arnaldo F B ^b   Sassi, Raul M ^a   Frasch, Carl E ^c   Milagres, Lucimar G ^b  

^a FEDERAL UNIVERSITY OF RIO GRANDE   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Bactericidal antibody and serological memory; Neisseria meningitidis; Vaccine

Indexed keywords

BACTERICIDE; BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; MENINGOCOCCUS VACCINE; OUTER MEMBRANE PROTEIN; VA MENGOC BC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; FEMALE; MENINGITIS; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; VACCINATION;

EID: 15044358011     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.femsim.2004.11.013     Document Type: Article

References (23)

1. L. Jódar, I.M. Feavers, D. Salisbury, and D.M. Granoff Development of vaccines against meningococcal disease Lancet 359 2002 1499 1508
2. J.C. Moraes, B.A. Perkins, M.C.C. Camargo, N.T.R. Hidalgo, H.A. Barbosa, C.T. Sacchi, I.M.L. Gral, V.L. Gattas, H.G. Vasconcelos, B.D. Plikaytis, J.D. Wenger, and C.V. Broome Protective efficacy of a serogroup B meningococcal vaccine in São Paulo Lancet 340 1992 1074 1078
3. Noronha, C.P., Baran, M., Nicolai, C.C.A., Azevedo, M.B., Bernardes, A.T.O., Monteiro, G.T.R., Lopes, G.R.S., Rodrigues, R.S., Santos, A.M. and Lemos, M.C.F. (1977). Epidemiologia da doença meningocócica na cidade do Rio de Janeiro: modificações após vacinação contra os sorogrupos B e C. Cad Saúde Públ. 13, 295-303
4. L.G. Milagres, M.C. Gorla, C.T. Sacchi, and M.M. Rodrigues Specificity of bactericidal antibody response to serogroup B meningococcal strains in Brazilian children after immunization with an outer membrane vaccine Infect. Immun. 66 1998 4755 4761
5. M.C.O. Gorla, A.P.S. Lemos, C.T. Sacchi, J.C. Moraes, and L.G. Milagres Comparison of PorA VR types and por A promoter sequence from Neisseria meningitidis B isolated from non-immunised children and vaccine failures immunized with a serogroup B outer membrane protein vaccine Vaccine 21 2003 2871 2876
6. J. Holst, B. Feiring, J.E. Fuglesang, E.A. Hoiby, H. Nokleby, I.S. Aaberge, and E. Rosenqvist Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease Vaccine 21 2003 734 737
7. E.D. de Kleijn, R. de Groot, A.B. Lafeber, J. Labadie, C.J. van Limpt, J. Visser, G.A. Berbers, L. van Alphen, and H.C. Rumke Prevention of meningococcal serogroup B infections in children: a protein-based vaccine induces immunologic memory J. Infect. Dis. 184 2001 98 102
8. E. Longworth, R. Borrow, D. Goldblatt, P. Balmer, M. Dawson, N. Andrews, E. Miller, and K. Cartwright Avidity maturation following vaccination with a meningococcal recombinant hexavalent PorA OMV vaccine in UK infants Vaccine 20 2002 2592 2596
9. J.W. Tappero, R. Lagos, A.M. Ballesteros, B. Plikaytis, D. Willians, J. Dykes, L.L. Gheesling, G.M. Carlone, E.A. Høiby, J. Holst, H. Nøkleby, E. Rosenqvist, G. Sierra, C. Campa, F. Sotolongo, J. Vega, J. Garcia, P. Herrera, J.T. Poolman, and B.A. Perkins Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines JAMA 281 1999 1520 1527
10. E. Wedege, E.A. Høiby, E. Rosenqvist, and G. Bjune Immune response against major outer membrane antigens of Neisseria meningitidis in vaccines and controls who contracted meningococcal disease during the Norwegian serogroup B protection trial Infect. Immun. 66 1998 3223 3231
11. L.G. Milagres, M.C.O. Gorla, M.C. Rebelo, and D.E. Barroso Bactericidal antibody response to Neisseria meningitidis serogroup B in patients with bacterial meningitis: effect of immunization with an outer membrane protein vaccine FEMS Immunol. Med. Microbiol. 28 2000 319 327
12. D. Goldblatt, A.R. Vaz, and E. Miller Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization J. Infect. Dis. 177 1998 1112 1115
13. C.L. Vermont, H.H. van Dijken, C.J. van Limpt, R. de Groot, L. van Alphen, and G.P. van Den Dobbelsteen Antibody avidity and immunoglobulin G isotype distribution following immunization with a monovalent meningococcal B outer membrane vesicle vaccine Infect. Immun. 70 2002 584 590
14. J. Tommassen, P. Vermeij, M. Struyve, R. Benz, and J.T. Poolman Isolation of Neisseria meningitidis mutants deficient in class 1 (PorA) and class 3 (PorB) outer membrane proteins Infect. Immun. 58 1990 1355 1359
15. ® against disease caused by serogroup B Neisseria meningitidis M. Achtman P. Kohl C. Marchal g. Morelli A. Seiler B. Thiesen Neisseria 1990 1991 Walter de Gruyter Berlin 129 134
16. L.G. Milagres, S.R. Ramos, C.T. Sacchi, C.E.A. Melles, V.S.D. Vieira, H. Sato, G.S. Brito, J.C. Moraes, and C.E. Frasch Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: comparison with efficacy Infect. Immun. 62 1994 4419 4424
17. B.D. Plikaytis, P.F. Holder, L.B. Pais, S.E. Maslanka, L.L. Gheesling, and G.M. Carlone Determination of parallelism and nonparallelism in bioassay dilution curves Clin. Microbiol. 32 1994 2441 2447
18. D. Goldblatt Simple solid phase assays of avidity M.W. Turner A.P. Johnson Immunochemistry 2: A Pratical Approach 1997 IRL Press at Oxford University press 31 51
19. E.E. Moran, B.L. Brandt, and W.D. Zollinger Expression of the L8 lipopolysaccharide determinant increases the sensitivity of Neisseria meningitidis to serum bactericidal activity Infect. Immun. 62 1994 5290 5295
20. J. Adu-Bobie, B. Capecchi, D. Serruto, R. Rappuoli, and M. Pizza Two years into reverse vaccinology Vaccine 2003 605 610
21. E. Rosenqvist, E.A. Høiby, E. Wedege, K. Bryn, J. Kolberg, A. Klem, E. Rønnild, G. Bjune, and H. NøKleby Human antibody responses to meningococcal outer membrane antigens after three doses of the Norwegian group B meningococcal vaccine Infect. Immun. 63 1995 4642 4652
22. A. Munkley, C.R. Tinsley, M. Virji, and J.E. Heckels Blocking of bactericidal killing of Neisseria meningitidis by antibodies directed against class 4 outer membrane protein Microb. Pathog. 11 1991 447 452
23. R. Nanan, D. Heinrich, M. Frosch, and H.W. Kreth Acute and long-term effects of booster immunization on frequencies of antigen-specific memory B-lymphocytes Vaccine 20 2002 498 504